Connect

Member Research and Reports

Member Research and Reports

Johns Hopkins Finds Association between SSRI Use During Pregnancy and Autism and Developmental Delays in Boys

In a study of nearly 1,000 mother-child pairs, researchers from the Johns Hopkins University Bloomberg School of Public Health found that prenatal exposure to selective serotonin reuptake inhibitors (SSRIs), a frequently prescribed treatment for depression, anxiety, and other disorders, was associated with autism spectrum disorder (ASD) and developmental delays (DD) in boys. The study, published in the online edition of Pediatrics, analyzed data from large samples of ASD and DD cases, and population-based controls, where a uniform protocol was implemented to confirm ASD and DD diagnoses by trained clinicians using validated standardized instruments.